Back to Search
Start Over
A retrospective research of HIV-negative cryptococcal meningoencephalitis patients with acute/subacute onset.
- Source :
-
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2016 Feb; Vol. 35 (2), pp. 299-303. Date of Electronic Publication: 2016 Jan 20. - Publication Year :
- 2016
-
Abstract
- Cryptococcal meningoencephalitis (CM) may present as an acute, subacute, or chronic infection. It manifests as a chronic process in over 75 % of cases, but, sometimes, it presents with a more acute onset, mostly in HIV-associated patients. Until now, there has been no study performed on the clinical features of HIV-negative CM patients with acute/subacute onset. We collected 106 HIV-negative patients diagnosed with CM in our hospital during a 15-year period, analyzed their epidemiological and clinical features, as well as the outcomes, and explored the independent prognosis factors and the factors related to the survival time among them. We found that impaired consciousness (23.4 % vs. 3.4 %, p = 0.017) was more common in CM patients with acute/subacute onset, while decreased cerebrospinal fluid (CSF) glucose (51.9 % vs. 75.9 %, p = 0.026) was less common. The ratio of CSF glucose/blood glucose [odds ratio (OR) 0.04, 95 % confidence interval (CI) 0.004-0.262, p = 0.02], impaired consciousness (OR 5.09, 95 % CI 1.477-17.522, p = 0.01), and hospitalization length (OR 0.98, 95 % CI 0.977-0.999, p = 0.04) were indicated to be not only independent prognosis factors in HIV-negative CM patients with acute/subacute onset, but also factors significantly related to the survival time. The results of our study demonstrated that the contact history and potential history risk factors would not affect the onset process of HIV-negative CM patients, and the mortality, hospitalization length, and survival time has not been related to the onset process. However, the ratio of CSF glucose/blood glucose, consciousness level, and hospitalization length of the HIV-negative CM patients with acute/subacute onset should be of greater focus in the clinical work.
- Subjects :
- Adolescent
Adult
Aged
Aged, 80 and over
Amphotericin B therapeutic use
Antifungal Agents therapeutic use
Child
Child, Preschool
Chronic Disease
Consciousness Disorders microbiology
Cryptococcus isolation & purification
Deoxycholic Acid therapeutic use
Drug Combinations
Female
HIV Infections
Hospitalization
Humans
Infant
Infectious Encephalitis drug therapy
Infectious Encephalitis microbiology
Infectious Encephalitis mortality
Male
Meningitis, Cryptococcal drug therapy
Meningitis, Cryptococcal microbiology
Meningitis, Cryptococcal mortality
Meningoencephalitis drug therapy
Meningoencephalitis microbiology
Meningoencephalitis mortality
Middle Aged
Retrospective Studies
Risk Factors
Young Adult
Blood Glucose analysis
Glucose cerebrospinal fluid
Infectious Encephalitis pathology
Meningitis, Cryptococcal pathology
Meningoencephalitis pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1435-4373
- Volume :
- 35
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
- Publication Type :
- Academic Journal
- Accession number :
- 26792138
- Full Text :
- https://doi.org/10.1007/s10096-015-2545-0